// App-Quantinova.ai

: Clustering Analysis of Myeloma Clone Phenotype Is Informative for Disease Heterogeneity and Prognosis at Relapse

Researchers

Presenter

  • Syeda Maheen Ahsan

Principal Investigators

  • Elisabet Nadal-Melsio

  • Mark E Robinson

  • Richard Syzdlo

  • Eva Yebra-Fernandez

  • Holger W Auner

  • Maria Atta

  • Marco Bua

  • Farah O'Boyle

  • Kikkeri Naresh

  • Jane Apperley

  • Anastasios Karadimitris

  • Aristeidis Chaidos

Medical Centers

  • Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom

  • Department of Haematology, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, United Kingdom

  • Department of Surgery & Cancer, Imperial College London, London, United Kingdom

  • Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 19

  • Cluster of Differentiation 38

  • Cluster of differentiation 45

  • Cluster of Differentiation 56

  • Syndecan-1

Drug/Treatment

  • Lanthanum carbonate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved